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Abstract
Chronic intestinal parasite infection is a major global health problem, but mechanisms that promote chronicity are poorly
understood. Here we describe a novel cellular and molecular pathway involved in the development of chronic intestinal
parasite infection. We show that, early during development of chronic infection with the murine intestinal parasite Trichuris
muris, TGFb signalling in CD4+ T-cells is induced and that antibody-mediated inhibition of TGFb function results in
protection from infection. Mechanistically, we find that enhanced TGFb signalling in CD4+ T-cells during infection involves
expression of the TGFb-activating integrin avb8 by dendritic cells (DCs), which we have previously shown is highly
expressed by a subset of DCs in the intestine. Importantly, mice lacking integrin avb8 on DCs were completely resistant to
chronic infection with T. muris, indicating an important functional role for integrin avb8-mediated TGFb activation in
promoting chronic infection. Protection from infection was dependent on CD4+ T-cells, but appeared independent of
Foxp3+ Tregs. Instead, mice lacking integrin avb8 expression on DCs displayed an early increase in production of the
protective type 2 cytokine IL-13 by CD4+ T-cells, and inhibition of this increase by crossing mice to IL-4 knockout mice
restored parasite infection. Our results therefore provide novel insights into how type 2 immunity is controlled in the
intestine, and may help contribute to development of new therapies aimed at promoting expulsion of gut helminths.
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Introduction
Gastrointestinal parasitic helminth infections are extremely
prevalent, affecting nearly one quarter of the world population.
Development of chronic infection, defined as the presence of adult
worms in the host, results in severe morbidity and health problems
and has been heavily linked with promotion of poverty in affected
regions [1]. Current treatments involve the use of anti-helminthic
drugs to kill the parasite, but this does not prevent rapid re-
infection with worms and encounters problems with drug
resistance. As infections with these intestinal parasites are usually
chronic, it is likely that helminths are able to influence the immune
system to prevent their expulsion. Therefore, understanding the
cellular and molecular pathways that regulate the immune
response during helminth infection will be crucial in identifying
novel therapeutic targets for these poorly managed infections.
A key cytokine that plays a multi-functional role in controlling
immune responses is transforming growth factor beta (TGFb) [2].
TGFb can affect many different cell types, with data highlighting a
crucial role for TGFb in regulation of CD4+ T-cells, both
dampening and promoting effector responses depending on the
context of the immune response [3,4]. Importantly, although
many cells can produce TGFb, it is always made as an inactive
complex that must be activated to produce biological function [5].
Thus, activation of TGFb is a key regulatory step in controlling the
function of TGFb in the immune system.
Given its importance in regulating diverse T-cell responses, it is
not surprising that TGFb plays a crucial role in the maintenance
of immune homeostasis and prevention of autoimmunity. Thus,
mice lacking TGFb receptors in T-cells develop multi-organ
inflammatory disease [6,7] and lack of TGFb production by T-
cells results in autoimmunity and colitis [8]. Interestingly, recent
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data has implicated TGFb-like molecules produced by helminths
in regulating immune responses during parasite infection [9].
However, the function of TGFb during helminth infection and
how it is regulated to control immune responses to intestinal
parasites is poorly understood.
Here we show that mice infected with the intestinal parasite
Trichuris muris, a homologue of the human pathogen Trichuris
trichuria [10], display enhanced TGFb signalling in CD4+ T-cells
early during infection and that antibody-mediated blockade of
TGFb significantly reduces worm burden during the development
of a chronic infection.. We find that integrin avb8 expressed by
dendritic cells (DCs), which we have previously shown to be a key
pathway in activating TGFb during intestinal homeostasis [11,12],
is required for early induction of TGFb signalling in CD4+ T-cells
during development of chronic helminth infection. Importantly,
mice lacking integrin avb8 expression on DCs are completely
protected from chronic infection, with this protection resulting
from a specific early upregulation of a Th2-type immune response.
Our results therefore provide novel insights into regulatory
mechanisms of importance during chronic gastrointestinal parasite
infection, and may help contribute to the development of new
therapies aimed at promoting expulsion of helminth infection.
Results
TGFb signalling in CD4+ T-cells is increased early during
development of chronic T. muris infection and blocking
TGFb protects mice from infection
Development of a chronic parasite infection is believed to result
from an inappropriate suppression of host immunity, although the
exact molecular mechanisms governing these pathways remain
unclear. Given the fundamental importance of CD4+ T-cells in
regulating parasite infection and the key role for TGFb in
regulating many aspects of T-cell biology, we analysed TGFb
signalling in T-cells during development of a chronic infection
with the helminth Trichuris muris. In C57BL/6 mice receiving 30 T.
muris eggs, a dose shown previously to induce a chronic infection
[13], we observed a specific increase in phosphorylation of Smad
2/3 (pSmad2/3) in mLN CD4+ T-cells, which is the initial
signalling event triggered by engagement of TGFb with its
receptor [14]. This increase in TGFb signalling was observed as
early as day 3 post-infection, and was still evident at day 7 post-
infection (Figure 1A and B), before returning to levels seen in
uninfected mice by day 14 post-infection (Figure 1B). Similar early
increases in CD4+ T-cell pSmad2/3 were also observed in cells
taken from the lamina propria of the parasite’s niche, the caecum
and proximal colon (Figure S1 in Text S1). These data indicate
that TGFb signalling in CD4+ T-cells is an early hallmark of
chronic T. muris infection.
To directly examine the functional importance of TGFb in the
development of a chronic T. muris infection, we injected C57BL/6
mice with a TGFb function-blocking antibody before and during
infection. Interestingly, mice receiving TGFb function-blocking
antibody were significantly protected from worm infection
(Figure 1C). Thus, our data indicate that, during development of
chronic infection, TGFb plays an important role in promoting
infection by the intestinal parasite T. muris.
Expression of integrin avb8 by DCs propagates TGFb
signalling in CD4+ T-cells and development of chronic
intestinal helminth infection
We next sought to determine the mechanisms responsible for
enhanced TGFb signalling and function during T. muris infection.
One potential explanation for enhanced TGFb signalling observed
in CD4+ T-cells is enhanced activation of host latent TGFb during
infection. We have recently identified integrin avb8, expressed by
DCs, as a key activator of latent TGFb in the intestine during
immune homeostasis [11,12]. Thus, to determine the importance
of this pathway in promoting TGFb signalling in CD4+ T-cells
during T. muris infection, we analysed T-cell responses in C57BL/
6 control mice and mice lacking integrin avb8 on DCs (Itgb8
(CD11c-Cre) mice) [11] during infection. Interestingly, the increase
in TGFb signalling observed in CD4+ T-cells early during T.muris
infection was significantly reduced in Itgb8 (CD11c-Cre) mice, with
pSmad2/3 levels remaining similar to those observed in uninfected
mice during the first week of infection (Figure 2A and B). This
integrin avb8-dependent induction of Smad2/3 phosphorylation
was confirmed by Western blot analysis for pSmad2/3 in purified
CD4+ T-cells from infected mice (Figure 2C). In contrast, we did
not observe any differences in pSmad2/3 induction in dendritic
cells between control and Itgb8 (CD11c-Cre) mice (Figure S2A and
B in Text S1), indicating that the integrin avb8-mediated TGFb
activation does not trigger autocrine TGFb signalling in DCs
during early infection.
To directly test whether DCs produced enhanced levels of
active TGFb via expression of integrin avb8 during T. muris
infection, we isolated DCs from control and Itgb8 (CD11c-Cre) mice
and measured their ability to activate TGFb using an established
active TGFb reporter cell line [15]. Indeed, we observed an
enhanced ability of intestinal DC activation to produce active
TGFb early during the development of chronic T. muris infection,
which was completely absent in DCs lacking expression of integrin
avb8 (Figure 2D). Thus, during development of chronic T. muris
infection, enhanced TGFb activation by integrin avb8 on DCs is
important in triggering TGFb signalling pathways in CD4+ T-
cells.
To determine whether TGFb activation by integrin avb8 on
DCs was functionally important during development of chronic
infection with T. muris, we analysed worm numbers in control and
Itgb8 (CD11c-Cre) mice infected with a chronic dose of T. muris
eggs. Strikingly, Itgb8 (CD11c-Cre) mice were completely protected
from chronic infection by T. muris at day 35 post-infection, with
Author Summary
Infection with intestinal parasitic worms is a major global
health problem, with billions of people infected world-
wide. Often these worms (known as helminths) develop a
long-lasting chronic infection, due to failure of the host to
mount the correct type of immune response that would
normally expel the parasite. However, how the immune
system is controlled leading to chronic helminth infection
is not well understood. Here we identify a novel pathway
of importance in the development of chronic helminth
infection. Using a model parasite which infects mice, we
find that a protein called transforming growth factor beta
(TGFb signals to T-cells early during the development of
chronic infection and that blocking this signal protects
mice from infection. We have also uncovered a key
pathway and cell type that controls TGFb function during
development of chronic infection. When a protein called
integrin avb8 is absent from dendritic cells of the immune
system, TGFb is no longer activated to signal to T-cells and
mice are able to mount a protective (type 2) immune
response resulting in worm expulsion. Our findings
therefore provide new insights into how chronic infections
develop and identify potential molecular targets for the
prevention of chronic helminth infection.
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mice showing protection as early as day 14 post-infection
(Figure 2E). Indeed, protection from infection observed in Itgb8
(CD11c-Cre) mice was even more pronounced than that observed
using antibody-mediated blockade of TGFb function (Figure 1C).
It has been reported that expression of CD11c-Cre may drive
recombination in a subset of CD4+ CD11clo activated T-cells [16],
and we have previously reported that integrin avb8 is expressed by
CD4+ T-cells [11]. Thus, to test whether protection from infection
in Itgb8 (CD11c-Cre) mice could be due to deletion of the integrin in
T-cell subsets, we infected mice lacking integrin avb8 on T-cells
via expression of CD4-Cre (Itgb8 (CD4-Cre) mice) [11]. In contrast
to Itgb8 (CD11c-Cre) mice, Itgb8 (CD4-Cre) mice showed no
protection from infection with T.muris (Figure S3A in Text S1)
and showed an identical parasite-specific IgG2a/IgG1antibody
bias which is associated with development of a chronic infection
(Figure S3B in Text S1). Taken together, these data suggest that
integrin avb8-mediated TGFb activation by DCs is essential in the
promotion of chronic T. muris infection.
Protection from infection in Itgb8 (CD11c-Cre) mice is
driven by CD4+ T-cells but appears independent of
Foxp3+ Tregs
We next sought to determine the mechanisms responsible for
protection from infection in mice lacking the TGFb-activating
integrin avb8 on DCs. CD4+ T-cells are key in promoting
expulsion of intestinal parasite infection, including T. muris [17],
and TGFb signalling is triggered in these cells early during
infection (Figure 1A and B). However, recent evidence has
proposed that novel innate lymphoid cells can play crucial roles in
the expulsion of several parasite infections [18,19,20,21]. Thus, to
determine the function of a CD4+ T-cell response in the expulsion
of T. muris observed in Itgb8 (CD11c-Cre) mice, we first bred mice
onto a C57BL/6 SCID background lacking all lymphocytes. In
the absence of total lymphocytes, protection from infection was
completely absent, with Itgb8 (CD11c-Cre) SCID2/2 mice
showing similar susceptibility to infection as control mice
(Figure 3A). To specifically test the role of CD4+ T-cells in
Figure 1. TGFb is functionally important in the development of chronic T. muris infection. (A) and (B) Analysis of p-Smad 2/3 in CD4+ T-
cells from mLN during development of a chronic T. muris infection in C57BL/6 mice. (A) Representative flow cytometry plots in naive mice and mice
analysed 3 or 7 days post-infection (p.i.), (B) analysis of p-Smad 2/3 (MFI) in mLN CD4+ T-cells at different timepoints during infection. Data (n = 4–8
mice per group) are from up to three independent experiments performed. (C) Worm burdens from control and anti-TGFb antibody (clone 1D11)-
treated C57BL/6 mice analysed at day 21–23 p.i. after infection with a chronic dose of T. muris eggs. Data (n = 7–9 mice per group) are from two
independent experiments performed. *, P,0.05; ***, P,0.005 via Kruskal–Wallis (B) and Student’s t-test (C), error bars represent SE of means.
doi:10.1371/journal.ppat.1003675.g001
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protection from infection observed in Itgb8 (CD11c-Cre) mice, we
depleted CD4+ T-cells using an anti-CD4 antibody (Figure S4A in
Text S1). Absence of CD4+ T-cells restored susceptibility to
infection in Itgb8 (CD11c-Cre) mice (Figure 3B). Taken together,
these results indicate that protection from infection in the absence
of integrin avb8 expression on DCs is not via a direct effect of
innate lymphoid cells, but driven by a classical CD4+ T-cell
response, although a role for innate cells in initial priming cannot
be ruled out.
CD4+ Foxp3+ regulatory T-cells (Tregs) have been implicated
in inhibiting immune responses to helminths [22] including some
strains of T. muris [23]. Additionally, we have previously shown
that integrin avb8-mediated TGFb activation by specialised
intestinal DCs is a crucial mechanism by which Foxp3+ Tregs
are induced in the gut [12], and that Itgb8 (CD11c-Cre) mice have
reduced Foxp3+ Treg levels in their intestine [11]. Thus, one
potential explanation for protection from infection in Itgb8
(CD11c-Cre) mice is that there is a reduced Treg response
induced during infection in these mice. To address this
possibility, we first directly assessed the role of Foxp3+ Tregs
during development of chronic T. muris infection by using the
DEREG mouse model on a C57BL/6 background, which allows
specific ablation of Foxp3+ Tregs by injection of diphtheria toxin
[24]. Despite robust depletion of Foxp3+ Tregs (Figure S4B in
Text S1) we did not see any enhanced ability of Foxp3+ Treg-
depleted mice to expel worms (Figure 3C). In agreement with a
lack of role for Foxp3+ Tregs in the development of chronic T.
muris infection, we did not see any enhancement of Foxp3+ Treg
levels during the course of infection (Figure 3D). Additionally, to
directly assess whether reduced Foxp3+ Treg numbers Itgb8
(CD11c-Cre) mice was responsible for protection from infection,
we rescued Treg numbers by adoptively transferred Foxp3+
Tregs from GFP-Foxp3 mice [25] prior to infection. Despite
enhancement of Treg numbers in Itgb8 (CD11c-Cre) mice after
adoptive transfer of GFP-Foxp3+ Tregs (Figure S5 in Text S1),
Itgb8 (CD11c-Cre) mice were still highly protected from develop-
ment of a chronic infection (Figure 3E). Taken together, these
data indicate that the protection from infection observed in Itgb8
(CD11c-Cre) mice is driven by CD4+ T-cells, but independently
of Foxp3+ Treg cells.
Itgb8 (CD11c-Cre) mice show a specific enhanced CD4+-
mediated IL-13 response early after infection
During development of a chronic infection with T. muris, mice
develop a Th1-type immune response at the expense of a
protective Th2-type response [13]. Thus, an alternative explana-
tion for the expulsion of a normally chronic infection of T. muris by
Itgb8 (CD11c-Cre) mice is that, in the absence of early CD4+ T-cell
TGFb signalling, mice produce a Th2-type response instead of the
usual non-protective Th1 response. To test this possibility, we
analysed the production of Th1 and Th2 cytokines during
infection in control and Itgb8 (CD11c-Cre) mice. Strikingly, as
early as 3 days post-infection, we observed a significant increase in
production of the Th2 cytokine IL-13, which was still elevated at 7
days post-infection (Figure 4A). In contrast, although there was a
slight enhancement of the Th1 cytokine IFNc 3 days post-
infection, this was not significantly different between control and
Itgb8 (CD11c-Cre) mice (Figure 4B). Control mice developed a
marked enhancement in IFNc production by day 18 post-
infection, as expected during development of a chronic infection,
and this was not observed in Itgb8 (CD11c-Cre) mice (Figure 4B).
Neither control nor Itgb8 (CD11c-Cre) mice produced any
detectable IL-4 at any tested timepoint post-infection, a cytokine
previously shown to be involved in protection from T. muris
infection (Figure S6 in Text S1 and data not shown).
We next investigated the cellular source of the early IL-13
production in Itgb8 (CD11c-Cre) mice using flow cytometry. We
observed a significant population of IL-13+ CD4+ T-cells within
the intestinal lamina propria early during infection in Itgb8 (CD11c-
Cre) which was not apparent in control mice (Figure 4C). We also
observed a slight increase in IFNc+ lamina propria CD4+ T-cells
in Itgb8 (CD11c-Cre) mice early post-infection; however, these levels
were not significantly different from those seen in control mice
(Figure 4C). Interestingly, in mice treated with a TGFb function-
blocking antibody which resulted in protection from infection
(Figure 1C), we observed a similar increase in CD4+ T-cell IL-13
production, with no difference in IFNc production observed
(Figure 4D). Furthermore, mice treated with TGFb blocking
antibody developed a skewed parasite-specific IgG1 response
during infection, indicative of an enhanced type2 immune
response (Figure 4E). Taken together, these data indicate that
TGFb activation by DC-expressed integrin avb8 is important in
controlling IL-13 production in CD4+ T-cells early during
development of chronic infection.
Enhanced type 2 cytokine production by Itgb8 (CD11c-
Cre) mice is responsible for rapid T. muris expulsion
To test whether the enhanced production of IL-13 early during
infection was responsible for expulsion of a chronic T. muris
infective dose, we crossed the Itgb8 (CD11c-Cre) mice with C57BL/
6 IL-4 knockout mice, which have previously been shown to lack
the ability to generate an IL-4/13-mediated Th2 response during
T. muris infection [26]. As both control mice and Itgb8 (CD11c-Cre)
mice did not display production of IL-4 early during T. muris
infection (Figure S6 in Text S1), these mice allowed us to test the
role of the enhanced IL-13 response seen early during infection in
Itgb8 (CD11c-Cre) mice. As expected, Itgb8 (CD11c-Cre)6IL-42/2
mice no longer demonstrated an early IL-13 production in the
intestinal CD4+ T-cells (Figure 5A). Strikingly, Itgb8 (CD11c-
Cre)6IL-42/2 mice were completely susceptible to infection, with
parasite burdens comparable to those seen in control mice
(Figure 5B). Taken together, these data indicate that lack of the
TGFb-activating integrin avb8 on DCs results in a heightened
CD4+ T-cell Th2 immune response during T. muris infection
which is responsible for rapid parasite expulsion.
Figure 2. Mice lacking the TGFb-activating integrin avb8 on DCs are protected from a chronic T. muris infection. (A) Representative flow
cytometry plots and (B) average MFI values for p-Smad 2/3 staining in CD4+ T-cells from control and Itgb8 (CD11c-Cre) mice at different times after
infection of mice with a chronic dose of T. muris eggs. Data (n = 5–8) are from three independent experiments performed. (C) Western blot analysis of
p-Smad2/3 and b-actin in purified CD4+ T-cells from control and Itgb8 (CD11c-Cre) mice at different times during infection with a chronic dose of T.
muris. Data representative of two independent experiments. (D) TGFb activation by intestinal DCs isolated from control or Itgb8 (CD11c-Cre) mice,
from naive mice or day 3 post-infection (p.i.) with a chronic dose of T. muris eggs, detected by co-culture with an active TGFb reporter cell line [15].
Data (n = 3–4) are from three independent experiments performed. (E) Worm burdens from control and Itgb8 (CD11c-Cre) mice at day 14 and 35 p.i.
with a chronic dose of T. muris eggs. Data (n = 9–10 mice per group) are from at least two independent experiments performed. *, P,0.05, ***,
P,0.005 via Kruskal–Wallis (B) and Student’s t-test (D and E) for the indicated comparisons between groups, error bars represent SE of means.
doi:10.1371/journal.ppat.1003675.g002
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Figure 3. Protection from chronic T. muris infection in mice lacking the TGFb-activating integrin avb8 on DCs is dependent on CD4+
T-cells, but does not involve Foxp3+ Tregs. (A) Worm burdens from control and Itgb8 (CD11c-Cre) mice crossed onto a SCID background
analysed at day 32 post-infection (p.i.) with a chronic dose of T.muris eggs. Data (n = 4–9 mice per group) are from two independent experiments
performed. (B) Worm burdens from Itgb8 (CD11c-Cre) mice infected with a chronic dose of T.muris eggs and treated with 2 mg of control IgG or anti-
CD4 antibody (YTS191) analysed at day 17 p.i. Data (n = 6 mice per group) are from two independent experiments performed. (C) Control and DEREG
mice were infected with a chronic dose of T. muris eggs, injected i.p. with 200 ng diphtheria toxin every 2 days (starting 2 days before infection) and
worm burdens analysed at day 14 p.i. Data (n = 10 mice per group) are from two independent experiments performed. (D) Percentage of Foxp3+
Tregs of CD4 T-cells in mLN, IEL and LILP populations during T. muris infection as analysed by flow cytometry. Data (n = 7–11 mice per group) are from
avb8 on DCs Regulates Type 2 Immunity
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Discussion
Infection with intestinal helminths can result in either expulsion
or development of chronic infection, often depending on the type
of CD4+ T-cell response generated. Generally, a chronic infection
results when inappropriate Th1 cytokine production occurs, as
opposed to an inability of CD4+ T-cells to mount a response.
Expulsion of the parasite relies on the production of Th2
cytokines, in particular IL-13 which drives a combination of
cytokine-mediated expulsion mechanisms such as increased
epithelial cell turnover in the intestine [27], enhanced mucus
production [28] and increased production of RELM-b [29]. Our
data now demonstrate an essential role for TGFb and the TGFb-
activating integrin avb8 expressed by DCs in promoting chronic
intestinal parasite infection, using T. muris, a mouse model of the
prevalent human parasite Trichuris trichuria. We observed that
TGFb signalling in CD4+ T-cells is triggered early during T. muris
infection, and antibody-mediated blockade of TGFb function
significantly protects mice from infection. Mechanistically, we find
that enhanced TGFb signalling in T-cells during infection occurs
via expression of the TGFb-activating integrin avb8 on DCs and
that lack of this integrin on DCs completely protects mice from
infection due to an enhanced protective Th2 response. We have
therefore identified a novel pathway that regulates Th2 immune
responses in the gut that could potentially be targeted to
upregulate host protective immune responses during gut parasite
infection.
Recent data suggest that in certain chronic parasite infections,
induction of Foxp3+ Tregs is important in suppression of
protective immunity and development of chronic infection
[30,31,32]. Given the fundamental role of TGFb in induction of
Foxp3+ Tregs from naive CD4+ T-cells, and the fact that Itgb8
(CD11c-Cre) mice have previously been shown to have impaired
induction of intestinal Foxp3+ Tregs [12], we hypothesised that
protection from T. muris infection observed in Itgb8 (CD11c-Cre)
mice was due to reduced induction of Foxp3+ Tregs. However,
when Foxp3+ Tregs were depleted before and during the course of
infection no protection from infection was observed. Indeed, in
contrast to Itgb8 (CD11c-Cre) mice, no enhancement of CD4+ T-
cell IL-13 production was observed early during infection in
Foxp3+ Treg-depleted mice (Figure S7 in Text S1). Additionally,
in agreement with previous reports [23] we did not see a
significant increase in Foxp3+ Tregs during T. muris infection.
Instead, TGFb activation by DC-expressed integrin avb8
appears important in suppression of IL-13 production by CD4+
T-cells early during T. muris infection. This is in agreement with
previous data from in vitro studies, suggesting that TGFb can
downregulate expression of GATA-3 in T-cells (a key transcription
factor in promoting Th2 cell differentiation) [33,34]. Indeed,
recent data suggest that TGFb-mediated induction of the
transcription factor Sox4 is important in preventing GATA-3
transcription to drive Th2 development [35]. Furthermore, we
only observed an early increase in CD4+ T-cell specific pSmad2/3
signalling during a chronic Th1-promoting low dose infection and
not during an acute Th2 promoting high dose infection in
C57BL/6 mice (Figure S8 in Text S1) Thus, our data suggests that
activation of TGFb by integrin avb8 early during T. muris
infection is important in suppression of protective Th2 cell
development, which leads instead to production of an inappro-
priate Th1 response and development of chronic infection.
Although we did not detect any IL-4 production in Itgb8
(CD11c-Cre) mice during infection, given that we crossed these
mice to IL4 KO mice to eliminate enhanced IL-13 production by
T-cells, we cannot rule out a potential role for low level production
of IL-4 (below our limits of detection) in protection from infection.
In addition to effects on T-cells, TGFb has wide-ranging effects
on multiple other immune cell types [36]. Recent reports have
highlighted an important role for novel innate lymphoid cells in
promoting protective type 2 immunity during certain parasite
infections [18,19,20,21]. Hence, it could be postulated that
protection from infection seen in the absence of integrin avb8
results from an enhanced innate lymphoid cell response. However,
protection from chronic T. muris infection observed in Itgb8
(CD11c-Cre) mice did not correlate with enhanced type 2 cytokine
production from any cell types apart from CD4+ T-cells (data not
shown), and protection from infection was completely dependent
on CD4+ T-cells. Thus, although innate lymphoid cell depletion
would be required to definitively rule out their role in this
enhanced Th2 response, it appears unlikely that lack of integrin-
mediated TGFb activation by DCs is promoting expulsion of the
parasite via effects on non-CD4+ T-cells.
Given the crucial importance of TGFb in regulating CD4+ T-
cell responses, our current model is that TGFb activated by DCs
acts directly in CD4+ T-cells to regulate type 2 responses during T.
muris infection. A recent study by Heitmann et al. (2012) suggests
that CD4+ T-cell type 2 responses can be regulated via TGFb
signalling in DCs [36]. Thus, mice expressing a dominant negative
construct of the TGFb receptor II in myeloid cells (hence are
refractory to TGFb signalling) display enhanced Th2 responses
during infection with the helminth Nippostrongylus brasiliensis [36].
However, we observed no difference in pSmad2/3 induction in
DCs from control versus Itgb8 (CD11c-Cre) mice early during
infection (Figure S2 in Text S1). Thus, our data indicate that
activation of TGFb by integrin avb8 on DCs does not regulate
Th2 cells indirectly via autocrine TGFb signalling during T. muris
infection.
Velhoden et al 2008 [37] have demonstrated that mice
expressing a dominant negative TGFb receptor specifically on
CD4+ T-cells (CD4-DN-TGFbRII mice, thus T-cells are refrac-
tory to TGFb) are more susceptible to infection with T. muris using
an acute model of infection. This finding initially appears to
conflict with our data, as we demonstrate that both antibody-
mediated blockade of TGFb and lack of the TGFb activating
integrin avb8 on DCs promotes expulsion of the parasite.
However, recent data suggests that CD4-DN-TGFbRII mice
display high levels of IFNc level during intestinal helminth
infection [38],[39] which, given the known role of IFNc in
promoting chronic T. muris infection [13], may explain the
enhanced levels of infection observed in CD4-DN-TGFbRII mice.
An important question that remains are which specific subset of
intestinal DCs are involved in modulating CD4+ T-cells to
suppress Th2 responses? Although a functionally important gut
population of CD11c+ T-cells does exist [16], which may be
targeted in our CD11c-cre knock-out system, mice lacking integrin
avb8 on T-cells (Itgb8 (CD4-Cre) mice) were completely susceptible
to T. muris infection (Figure S3 in Text S1). These data indicate
four independent experiments. (E) Caecal lamina propria worm burdens in control, Itgb8 (CD11c-Cre) and Itgb8 (CD11c-Cre) mice injected with 0.56106
GFP-Foxp3+ CD4 T-cells 3 days prior to infection. All mice received a chronic dose of T. muris and were analysed at day 14 p.i. for worm burden or day
3 p.i. for reconstitution. Data (n = 3–4 mice per group) are from three independent experiments. **, P,0.01; or ***, P,0.005, N.S., not significant via
Kruskal–Wallis (D) and Student’s t-test (A, B, C and E) for the indicated comparisons between groups, error bars represent SE of means.
doi:10.1371/journal.ppat.1003675.g003
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Figure 4. Mice lacking the TGFb-activating integrin avb8 on DCs demonstrate an enhanced IL-13 production in LILP CD4+ T-cells. (A)
IL-13 and (B) IFNc cytokine levels from T. muris E/S antigen-stimulated mLN cells from control and Itgb8 (CD11c-Cre) mice at different time-points
post-infection ( p.i.) with a chronic dose of T. muris eggs, determined via cytometric bead array/ELISA. Data (n = 5–6 mice per group) are from three or
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that it is indeed an avb8-expressing DC population (or a related
CD11c+ mononuclear phagocyte population) that is important in
inhibiting Th2 responses in this infection. An important DC subset
likely involved during infection are the migratory CD103+ DC
[40], as we have previously demonstrated that this cell subset
expresses high levels of integrin avb8 [12]. We have observed
some integrin avb8 expression on the CD11c+ CD103- DC subset
in the colon [12], which has been suggested to include both DCs
more independent experiments. (C) Analysis of intracellular IL-13 and IFNc expression in CD4+ T-cells isolated from control and Itgb8 (CD11c-Cre) mice
at day 3 p.i. with a chronic dose of T. muris eggs. Representative flow cytometry plots and mean data are displayed. Data (n = 5–6 mice per group
mice per group) are from three independent experiments. (D) Representative flow cytometry plots for IL-13 and IFNc from LILP CD4+ T-cells at day 3
p.i. and (E) Serum antigen specific IgG1 and IgG2a levels at day 21–23 p.i. from control and anti-TGFb antibody-treated C57BL/6 mice infected with a
chronic dose of T. muris eggs. Data (n = 7–9 mice per group) are from two independent experiments performed. *, P,0.05; **, P,0.01; or ***,
P,0.005, N.S., not significant via Kruskal–Wallis (A and B) and Student’s t-test (C and E) for the indicated comparisons between groups, error bars
represent SE of means.
doi:10.1371/journal.ppat.1003675.g004
Figure 5. Ablation of enhanced IL-13 production by CD4+ T-cells in Itgb8 (CD11c-Cre)mice restores susceptibility to infection with T.
muris. (A) IL-13 production by LILP CD4+ T-cells isolated day 3 post-infection (p.i.) with a chronic dose of T. muris eggs in IL-42/2 control and Itgb8
(CD11c-Cre) IL-42/2 mice. Representative flow cytometry plots and mean data are displayed. Data (n = 5–6 mice per group) are from two
independent experiments. Data (n = 5–6) are from two independent experiments performed. (B) Worm burdens from IL-42/2 and Itgb8 (CD11c-Cre)
IL-42/2 mice at day 14 p.i. with a chronic dose of T. muris eggs. Data (n = 5–6 mice per group) are from two independent experiments. **, P,0.01;
N.S., not significant via Student’s t –test for the indicated comparisons between groups, error bars represent SE of means.
doi:10.1371/journal.ppat.1003675.g005
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and macrophage-like cell populations [41]. However, although
some subsets of CD11c+ CD103- intestinal cells have been shown
to migrate to lymph nodes to modulate T-cell responses [42], a
large population do not normally migrate. Of note, we did not
observe any alteration in the levels of avb8 expression on either
CD103+ or CD103- LILP subset during the development of a
chronic infection (Figure S9 in Text S1). Therefore, the exact DC
population involved in downregulation of Th2 responses via
integrin avb8 remains to be determined. Nevertheless, this key
role for DC-expressed integrin avb8 in modulating Th2 responses,
in addition to its previous essential roles in the induction of Foxp3+
Tregs [12] and Th17 cells [43], places DC-expressed integrin
avb8 as a key orchestrator of CD4+ T-cell immunity.
In summary, we have highlighted an important cellular and
molecular pathway by which the TGFb-activating integrin avb8
expressed by DCs represses protective Th2 immunity during
intestinal parasite infection with T. muris. Thus, given the poor
treatments currently available for chronic parasite infection,
further work should focus on the potential for targeting integrin
avb8 therapeutically to enhance protective immunity during
Trichuris infection. Additionally, whether the pathway is involved
in the development of other chronic infections and Th2-associated
disease is the focus of current studies.
Materials and Methods
Animals
C57 BL/6 mice were purchased from Harlan Laboratories.
Mice lacking integrin avb8 on DCs via expression of a conditional
floxed allele of b8 integrin in combination with CD11c-Cre (Itgb8
(CD11c-Cre) mice) [11], DEREG mice [24], GFP-Foxp3 mice [25]
and IL-42/2 mice [44], all on a C57BL/6 background, have
been previously described. All mice were maintained in specific
pathogen-free conditions at the University of Manchester and used
at 6 to 8 weeks of age.
Ethics statement
All animal experiments were performed under the regulations of
the Home Office Scientific Procedures Act (1986), specifically
under the project licence PPL 40/3633. The project licence was
approved by both the Home Office and the local ethics committee
of the University of Manchester.
Trichuris muris infection
The techniques used for maintenance and infection of T. muris
were as previously described [45] Mice were orally infected with
20–30 eggs for a low-dose infection and 150 for an acute infection.
Worm burdens were assessed by counting the number of worms
present in the caecum as described previously [45].
Antibody-mediated TGFb blockade and cell depletion
To block TGFb, mice were injected i.p with 0.5 mg of anti-
TGFb blocking antibody (clone 1d11.16.8) (BioXCell, NH, USA)
or control IgG1 every 2 days from 4 days prior to infection. CD4+
cells were depleted via i.p. injection of 2 mg anti-CD4 antibody
(YTS 191)47 every 2 days from 6 days prior to infection. Foxp3+
Tregs were depleted in DEREG mice as described [24], via i.p.
injection of 200 ng diphtheria toxin (Merck) every 2 days from 2
days prior to infection.
Adoptive transfer of Foxp3+ Tregs
Spleens were removed from Foxp3GFP mice, disaggregated and
red blood cells lysed. Cells were blocked with anti-FccR antibody
and labelled with anti-CD4 antibody (clone GK1.5; eBioscience)
before sorting for CD4+, GFP+ populations using a FACS Aria.
Cell purity in all experiments was.99.8%. Mice were injected i.p.
with 0.56106 cells 3 days prior to infection.
DC purification
mLNs were excised from mice and incubated with shaking for
20 min at 37uC in RPMI with 0.08 U/ml liberase blendzyme 3
(Roche) or 1 mg/ml collagenase VIII and 50 U/ml DNAseI,
respectively. Cells were blocked with anti-FccR antibody (clone
24G2; eBioscience) before enrichment using a CD11c enrichment
kit and LS MACS column (Miltenyi Biotec). Enriched DCs were
labelled with anti-CD11c antibody (clone N418; eBioscience) and
sorted using a FACS Aria. In all experiments, subset purity was
.95%.
TGFb activation assay
DCs were incubated with mink lung epithelial cells transfected
with a plasmid containing firefly luciferase cDNA downstream of a
TGFb-sensitive promoter [15] in the presence of 1 mg/ml
lipopolysaccharide. Co-cultures were incubated overnight in the
presence of 80 mg/ml control mIgG or anti-TGFb antibody (clone
1d11) and luciferase activity detected via the Luciferase Assay
System (Promega) according to manufacturer’s protocol. TGFb
activity was determined as the difference in luciferase activity
between control mIgG-treated samples and samples treated with
anti-TGFb antibody.
Flow cytometry staining
Mesenteric lymph nodes (mLNs) were removed from mice and
disaggregated through a 100 mm sieve. Caecum and proximal
colon were excised and lamina propria lymphocytes were
prepared essentially as described [46] with slight modification in
the tissue digestion step (digestion medium used was RPMI with
10% Foetal calf serum, 0.1% w/v collagenase type I and Dispase
II (both Invitrogen), and tissue was digested for 30 min at 37uC).
Cell suspensions were blocked with anti-FccR antibody (clone
24G2; eBioscience) before labelling with antibodies specific for
CD4 (clone GK1.5; eBioscience), Foxp3 (clone FJK-16s;
eBioscience), IL-13 (clone eBiol13A; eBioscience), IFNc (clone
XMG1.2; eBioscience) or p-Smad 2/3 (Santa Cruz). For pSmad2/
3 staining, an Alexa Fluor 594-labelled donkey anti-goat secondary
antibody was used (Invitrogen). All samples were analysed on a
FACS LSRII.
Cell re-stimulation
mLN and LILP cells were prepared as described above before
incubating with 50 ug/ml of concavelin A or T. muris excretory/
secretory (E/S) antigen for 48 hours. Cell-free supernatants were
analysed for cytokine production via cytometric bead array (BD)
or paired ELISA antibodies (anti- IFNc, clone XMG1.2 and biotin
anti- IFNc, clone R4-6A2; anti-IL-13, clone eBio13A and biotin
anti-IL-13, clone eBio1316H and anti-IL-4, clone 11B1and biotin
anti-IL-4, clone BVD6-2462 (eBioscience). For intracellular
cytokine analysis cells were incubated for 12 hours with 50 ug/
ml T. muris E/S antigen followed by PMA/ionomycin stimulation
for 4 hour with addition of monensin for the final 3 hours. Cells
were then stained with antibodies against IL-4, IL-13 and IFNc
using the eBioscience Foxp3 permibilization kit according to the
manufacturer’s instructions.
Western blot
CD4+ T-cells were isolated from mLN via negative selection
using a CD4+ T-cell isolation kit (Miltenyi Biotec) during the
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course of a chronic T. muris infection and lysed using 1% Triton-
X100 in Tris buffer (50 mM Tris-HCl, 150 mM NaCl pH 7.4)
plus 5 mM EDTA, 20 mg/ml leupeptin and aprotinin, 0.5 mM
AESF and 2 mM NaVO3. Lysates were analysed by Western blot
with antibodies to detect p-Smad 2/3 (Millipore) and b-actin
(Sigma Aldrich), using the Invitrogen Nupage gel system according
to manufacturer’s instructions.
Quantitative PCR
Total RNA was purified from sorted DC subsets using an
RNAeasy minikit according to manufacturer’s protocol (Qiagen).
RNA was reverse transcribed using Oligo dT primers, and cDNA
for specific genes detected using a SYBR green qPCR kit
(Finnzymes) Gene expression normalised to HPRT expression.
HPRT Forward: GCGTCGTGATTAGCGATGATGAAC,
HPRT Reverse: GAGCAAGTCTTTCAGTCCTGTCCA, Inte-
grin b8 Forward: GGGTGTGGAAACGTGACAAGCAAT, Inte-
grin b8 Reverse: TCTGTGGTTCTCACACTGGCAACT.
Statistical analysis
Results are expressed as mean 6 SEM. Where statistics are
quoted, 2 experimental groups were compared using the Student’s
t-test for non-parametric data. Three or more groups were
compared using the Kruskal–Wallis test, with Dunn’s multiple
comparison post-test. P#0.05 was considered statistically signifi-
cant.
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